SZLS — StageZero Life Sciences Ltd. | ScreenerHero

SZLSStageZero Life Sciences Ltd.

TSX · CA · Health Care · Biotechnology

0.0400CAD0.00%Mkt Cap: 4.94M CADP/E: —Last update: 2026-05-25

Industry Peers

Biotechnology

Vertex Pharmaceuticals Incorporated

110.61BUSDP/E 25.8

105.81BDKKP/E 20.4

Regeneron Pharmaceuticals, Inc.

66.47BUSDP/E 15.5

46.56BEURP/E 30.5

43.89BEURP/E 36.5

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

Revolution Medicines, Inc.

Camurus AB (publ)

32.05BSEKP/E 47.4

Indicators:|

Key Statistics

Company

Market Cap4.94M CAD

Enterprise Value—

Revenue (TTM)—

Gross Profit-403.75K CAD

Net Income (TTM)-11.42M CAD

Revenue/Share—

Last Price0.0400 CAD

Fiscal Year End—

MR Quarter—

Employees—

CountryCA

SectorHealth Care

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.00

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-0.44

EPS (TTM)—

EPS (Forward)—

52W Range

—

52W High0.0400 CAD

52W Low0.0400 CAD

Profitability

Gross Margin-10.64%

Oper. Margin—

EBITDA Margin—

Profit Margin-300.79%

ROE152.14%

ROA-1629.25%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-3.53M CAD

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity-0.24

Current Ratio—

Quick Ratio—

Book Value/Sh-0.0900 CAD

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay DateSep 18, 2020

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.123.53M

Float—

Insiders—

Institutions—

Technical

SMA 500.0400 (-0.0%)

SMA 2000.0400 (-0.0%)

Beta—

S&P 52W Chg—

Avg Vol (30d)0

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—